Mayinglong Pharmaceutical Group Co Ltd (600993) — Financial Flexibility Index
Mayinglong Pharmaceutical Group Co Ltd (600993) has a Financial Flexibility Index of 0.17x as of September 2025. Free cash flow of CN¥152.93 Million (operating CF CN¥139.20 Million minus capex CN¥13.73 Million) represents 0% of total liabilities (CN¥909.82 Million). Also explore net asset growth rate of Mayinglong Pharmaceutical Group Co Ltd to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Mayinglong Pharmaceutical Group Co Ltd Financial Flexibility Index (2003–2025)
Historical Financial Flexibility Index trend for Mayinglong Pharmaceutical Group Co Ltd across 23 annual periods. Check Mayinglong Pharmaceutical Group Co Ltd PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Mayinglong Pharmaceutical Group Co Ltd (2003–2025)
Year-by-year free cash flow to debt coverage for Mayinglong Pharmaceutical Group Co Ltd. For the full company profile including market capitalisation, see Mayinglong Pharmaceutical Group Co Ltd (600993) total market value.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.78x | CN¥719.82 Million | CN¥600.44 Million | CN¥921.49 Million | ▲ +9.2% |
| 2024 | 0.72x | CN¥701.46 Million | CN¥497.61 Million | CN¥980.66 Million | ▼ -19.5% |
| 2023 | 0.89x | CN¥852.43 Million | CN¥604.07 Million | CN¥959.62 Million | ▲ +206.6% |
| 2022 | 0.29x | CN¥416.86 Million | CN¥341.85 Million | CN¥1.44 Billion | ▼ -64.4% |
| 2021 | 0.81x | CN¥662.27 Million | CN¥597.17 Million | CN¥812.72 Million | ▲ +128.3% |
| 2020 | 0.36x | CN¥328.40 Million | CN¥282.99 Million | CN¥919.89 Million | ▼ -56.8% |
| 2019 | 0.83x | CN¥537.94 Million | CN¥491.58 Million | CN¥650.49 Million | ▲ +42.6% |
| 2018 | 0.58x | CN¥333.21 Million | CN¥308.24 Million | CN¥574.67 Million | ▼ -29.7% |
| 2017 | 0.82x | CN¥398.08 Million | CN¥356.17 Million | CN¥482.99 Million | ▲ +29.7% |
| 2016 | 0.64x | CN¥304.84 Million | CN¥239.60 Million | CN¥479.88 Million | ▲ +8.4% |
| 2015 | 0.59x | CN¥306.78 Million | CN¥182.85 Million | CN¥523.31 Million | ▲ +30.6% |
| 2014 | 0.45x | CN¥218.54 Million | CN¥111.67 Million | CN¥486.89 Million | ▼ -3.1% |
| 2013 | 0.46x | CN¥213.62 Million | CN¥129.94 Million | CN¥461.22 Million | ▼ -6.1% |
| 2012 | 0.49x | CN¥202.01 Million | CN¥169.25 Million | CN¥409.56 Million | ▲ +38.7% |
| 2011 | 0.36x | CN¥120.06 Million | CN¥75.37 Million | CN¥337.70 Million | ▲ +416.9% |
| 2010 | 0.07x | CN¥22.13 Million | CN¥-11.42 Million | CN¥321.68 Million | ▼ -89.5% |
| 2009 | 0.65x | CN¥251.05 Million | CN¥216.11 Million | CN¥384.11 Million | ▲ +40.7% |
| 2008 | 0.46x | CN¥135.43 Million | CN¥102.59 Million | CN¥291.46 Million | ▲ +256.0% |
| 2007 | 0.13x | CN¥31.13 Million | CN¥6.49 Million | CN¥238.53 Million | ▼ -66.1% |
| 2006 | 0.39x | CN¥96.59 Million | CN¥75.27 Million | CN¥250.53 Million | ▼ -28.3% |
| 2005 | 0.54x | CN¥94.38 Million | CN¥58.43 Million | CN¥175.45 Million | ▼ -15.4% |
| 2004 | 0.64x | CN¥83.13 Million | CN¥54.19 Million | CN¥130.74 Million | ▲ +5.9% |
| 2003 | 0.60x | CN¥82.05 Million | CN¥67.52 Million | CN¥136.61 Million | — |